Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
about
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseTDP-43 in aging and Alzheimer's disease - a reviewTDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodiesOn the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.Biomarkers in frontotemporal lobar degeneration.Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes.Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.Biomarkers in the primary progressive aphasiasThe Role of TDP-43 in Alzheimer's Disease.Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations.TDP-43 plasma levels are higher in amyotrophic lateral sclerosis.Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.Towards a TDP-43-Based Biomarker for ALS and FTLD.[German consortium for frontotemporal lobar degeneration].Biomarkers in frontotemporal dementiaLimited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
P2860
Q26853347-A41B03B3-CC58-437F-8D8C-82CB95A97881Q34566756-A336B9BB-D8E2-411B-8BEC-34C7F7C13C47Q35234677-C0725ADA-2FF6-421F-83A0-0941727A28ECQ35592875-51E24424-AFE6-4E68-81A2-957F88CDE086Q37794615-C4CEC2FA-8591-47E7-B8B9-F93D44E64524Q37874158-0C436418-48C8-466E-BAAA-7408401FD4BCQ37915345-9E203444-FA89-4E95-BBF2-D1FD6CDC082BQ38096349-13DECB1C-D094-4630-A307-B90E3DFB38ACQ38314824-ECFEB7CC-FBA0-4D66-B371-F341B4C8A442Q38529627-F81744D3-D5A7-4F89-9948-DB2A611A2624Q39091938-8C4DC528-2A83-4A98-BE04-D37F81A40F7DQ39811341-5A440EC9-DF01-4CAE-BADE-1A84F26961DEQ47290748-9F549E8B-2998-47C3-9AC6-C58950A55837Q47896160-9FDDE94F-C246-424F-AE62-057C6C77BCA3Q48824117-7E5AE1FB-F019-410D-B22C-4E1149660783Q49823859-00100ED4-6073-4F1B-AD62-2E1593B2E4F3Q54058844-8F105262-FBFF-47BC-9655-352BC78FAAB9Q57911950-8A658EDB-250C-43C7-9632-3C46FEFCB715Q58292492-746CF9B7-80F4-4B34-9B80-CB64EDD84869
P2860
Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@ast
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@en
type
label
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@ast
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@en
prefLabel
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@ast
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@en
P2093
P2860
P1476
Plasma phosphorylated-TDP-43 p ...... totemporal lobar degeneration.
@en
P2093
David J Hobson
David M A Mann
Eileen H Bigio
Haruhiko Akiyama
Kirsty M Humphreys
Manjari Mishra
Mark Taylor
Masato Hasegawa
Nancy Johnson
Penelope G Foulds
P2860
P2888
P304
P356
10.1007/S00401-009-0594-0
P577
2009-10-13T00:00:00Z
P5875
P6179
1015948598